Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Systemic treatments for metastatic disease
| Systemic treatments | Total (n = 80), n (%) |
|---|---|
| Lines of all treatments, median (range) | 2 (1–9) |
| Lines of all treatments | |
| 1 | 22 (27.5) |
| 2 | 26 (32.4) |
| 3 | 18 (22.5) |
| 4 | 7 (8.8) |
| ≥5 | 7 (8.8) |
| Lines of immunotherapy treatments | |
| 1 | 22 (27.5) |
| 2 | 27 (33.8) |
| 3 | 17 (21.2) |
| 4 | 8 (10.0) |
| ≥5 | 6 (7.5) |
| Immunotherapy treatment | |
| Anti–PD‐1 monotherapya | 40 (50.0) |
| Anti–PD‐1 + anti‐CTLA4b | 40 (50.0) |
Either nivolumab or pembrolizumab.
Nivolumab plus ipilimumab.
